Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Eribulin Mesilate Injection

Approval Number

国药准字H20249690

Company正大天晴药业集团股份有限公司

Registration Date

December 6, 2024

Drug Information

Generic Name

甲磺酸艾立布林注射液

Dosage Form

注射剂

Strength

2ml：1mg

Drug Type

化学药品

Registration Date

December 6, 2024

Company Information

Applicant Company

Company Name正大天晴药业集团股份有限公司

Company Address

江苏省连云港市郁州南路369号

Manufacturing Company

Company Name正大天晴药业集团股份有限公司

Company Address

江苏省连云港市郁州南路369号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

甲磺酸艾立布林注射液 - NMPA 批准文号 | MedPath